Joe Sabatino
banner
jsabatino37.bsky.social
Joe Sabatino
@jsabatino37.bsky.social
MS Neurologist, T cell immunologist, UCSF Dept of Neurology, Weill Institute for Neurosciences.

All posts are my own and not on behalf of UCSF
November 25, 2025 at 5:30 PM
It was never as good as Twitter in my opinion, but my feeds on both platforms have gradually gone quieter over the last couple of years. I think many people have just lost interest unfortunately. It's a shame because it's by far and away the best way to share new science.
October 8, 2025 at 2:10 PM
4/ Comparing GA versus IFNb-treated patients, the protective effect of GA was observed specifically within A3+ carriers – i.e. GA-treated A3+ patients did better than IFNb-treated A3+ patients
July 31, 2025 at 6:20 PM
3/ A3 is best known in MS as a risk allele that increases disease susceptibility. Fascinatingly, GA-treated A3+ carriers have significantly better clinical and MRI outcomes compared to A3- carriers, independent of HLA-DR1*15:01 status
July 31, 2025 at 6:20 PM
2/ We observed that glatiramer acetate (GA) induced a unique population of CD8+ T cells specifically in HLA-A*03:01 (A3) carriers, across multiple independent patient cohorts
July 31, 2025 at 6:20 PM
Grateful for the initiative #SB829 proposed by CA state senator @scottwiener.bsky.social for a new California Institute for Scientific Research to continue supporting lifesaving research!

#standupforscience
May 16, 2025 at 10:21 PM
Amazing turnout for the #standupforscience rally in San Francisco!! @standupforscience.bsky.social
March 7, 2025 at 10:11 PM